.Pharmacolibrary.Drugs.D_Dermatologicals.D01A_AntifungalsForTopicalUse.D01AA08_Griseofulvin.Griseofulvin .Pharmacolibrary.Drugs.D_Dermatologicals.D01A_AntifungalsForTopicalUse.D01AA08_Griseofulvin.Griseofulvin| name: | Griseofulvin |
| ATC code: | D01AA08 | route: | oral |
| n-compartments | 1 |
Griseofulvin is an antifungal medication used for the treatment of fungal infections of the skin, hair, and nails, such as dermatophytosis. It acts by inhibiting fungal cell mitosis and is administered orally. Griseofulvin is still approved and in use today, though newer agents may be preferred for some infections.
Pharmacokinetic parameters reported for healthy adult volunteers following oral administration.
Gupta, AK, et al., & Cooper, EA (2003). The efficacy and safety of terbinafine in children. Journal of the European Academy of Dermatology and Venereology : JEADV 17(6) 627–640. DOI:10.1046/j.1468-3083.2003.00691.x PUBMED:https://pubmed.ncbi.nlm.nih.gov/14761128
Silva, MI, et al., & Halbert, GW (2023). Fed intestinal solubility limits and distributions applied to the Developability classification system. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 186 74–84. DOI:10.1016/j.ejpb.2023.03.005 PUBMED:https://pubmed.ncbi.nlm.nih.gov/36934829
Gupta, AK, et al., & Tavakkol, A (2005). The use of terbinafine in the treatment of onychomycosis in adults and special populations: a review of the evidence. Journal of drugs in dermatology : JDD 4(3) 302–308. PUBMED:https://pubmed.ncbi.nlm.nih.gov/15898285